Early discontinuation of tamoxifen : A Lesson for oncologists
✍ Scribed by Thomas I. Barron; Róisín Connolly; Kathleen Bennett; John Feely; M. John Kennedy
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 165 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The surgical oncologist is frequently responsible for the screening and diagnosis of women with breast cancer. In this pivotal role, they are often the first to discuss treatment options, including nonsurgical interventions, with breast cancer patients. Recent long-term clinical trial data provide s
## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi
## Abstract The PROSPECT (Prevention of Suicide in Primary Care Elderly — Collaborative Trial) Study evaluates collaborative care for the treatment of current depressive disorders in older primary care patients. Using screening data, we evaluate implications of expanding the focus to additional pat